冠動脈疾患の世界市場レポート 2025年

冠動脈疾患の有病率の増加は、今後数年間の冠動脈疾患市場の成長を促進すると予測されています。冠動脈疾患（CAD）は、心筋に血液を供給する冠動脈の狭窄や閉塞によって特徴づけられる病状です。CAD症例の増加は、食生活の変化、ストレス、運動不足、肥満、加齢、その他の要因に起因しています。冠動脈疾患の治療法には、クロピドグレル、チカグレロル、ワルファリン、ヘパリンなどの薬物療法や、冠動脈バイパス移植術、血管形成術、ステント留置術などの処置があります。例えば、2024年5月、米国に拠点を置く保健社会福祉省傘下の連邦政府機関である疾病対策予防センター（CDC）は、冠動脈性心疾患（CHD）が心臓病の主要なタイプであり、2022年には371,506人が死亡したと報告しました。20歳以上の成人の約5％（20人に1人）が冠動脈疾患（CAD）に罹患しています。2022年には、心血管疾患（CVD）による死亡の約5人に1人が65歳未満の成人で発生しています。したがって、冠動脈疾患の有病率の上昇は、予測期間中の冠動脈疾患市場を押し上げると予想されます。

高齢化人口の増加は、今後の冠動脈疾患市場の成長を牽引すると予想されます。高齢化とは、時間の経過とともに社会における高齢者の割合が増加することを特徴とする人口動態の変化を指します。この高齢化社会は、冠動脈疾患市場の拡大に大きく寄与しています。例えば、2022年10月、スイスに本部を置く国際的な公衆衛生に焦点を当てた機関である世界保健機関（WHO）の報告書によると、2030年までに世界で6人に1人が60歳以上になると予測されています。2050年までには、世界の60歳以上の人口は21億人に達すると予想されています。したがって、高齢化人口の増加が冠動脈疾患市場を牽引しています。

冠動脈疾患市場内の有力企業は、AIベースの血液検査などの最先端技術の開発に力を注いでいます。これらの検査は、血液関連データの分析と解釈に人工知能（AI）アルゴリズムを活用しています。例えば、2023年2月、AIベースの遺伝子・エピジェネティック統合エンジンを専門とする米国のCardio Diagnostics Holdings社は、PrecisionCHDを発表しました。この革新的な血液検査は、遺伝子解析とエピジェネティック解析を組み合わせ、冠動脈性心疾患の早期発見を可能にします。男女ともに75％以上の感度を持つPrecisionCHDは、エピジェネティック（DNAメチル化）および遺伝的（一塩基多型）バイオマーカーを組み込んだ、数十億のゲノムおよびエピジェノミック・データポイントの解析から得られた機械学習モデルを採用しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界冠動脈疾患PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の冠動脈疾患市場：成長率分析
• 世界の冠動脈疾患市場の実績：規模と成長, 2019-2024
• 世界の冠動脈疾患市場の予測：規模と成長, 2024-2029, 2034F
• 世界冠動脈疾患総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の冠動脈疾患市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬
• 手術
• 追加療法
• その他の治療法
• 世界の冠動脈疾患市場診断による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心電図
• 心エコー検査
• ストレステスト
• 心臓カテーテル検査
• 心臓CTスキャン
• その他の診断
• 世界の冠動脈疾患市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他のチャンネル
• 世界の冠動脈疾患市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• その他のエンドユーザー
• 世界の冠動脈疾患市場、医薬品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗血小板薬
• ベータ遮断薬
• スタチン
• ACE阻害薬
• その他の医薬品
• 世界の冠動脈疾患市場、手術の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 冠動脈バイパス移植
• 血管形成術とステント留置術
• 心臓弁手術
• その他の外科的介入
• 世界の冠動脈疾患市場、追加療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓リハビリテーション
• ライフスタイル修正プログラム
• 代替療法
• 世界の冠動脈疾患市場、その他の治療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝子治療
• 幹細胞療法
• 革新的なデバイス

第7章 地域別・国別分析

• 世界の冠動脈疾患市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の冠動脈疾患市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 冠動脈疾患市場：競合情勢
• 冠動脈疾患市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• Gilead Sciences Inc.
• Amgen Inc.
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Aurobindo Pharma Ltd.
• Hikma Pharmaceuticals plc
• Amneal Pharmaceuticals Inc.
• Chiesi Farmaceutici S.p.A.
• Lupin Pharmaceuticals Inc.
• Wockhardt Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 冠動脈疾患市場2029：新たな機会を提供する国
• 冠動脈疾患市場2029：新たな機会を提供するセグメント
• 冠動脈疾患市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Coronary artery disease (CAD) is a medical condition affecting the coronary arteries, responsible for supplying oxygen-rich blood to the heart muscle. The disease occurs when these arteries become narrowed or obstructed due to the accumulation of plaque-a buildup of cholesterol, fat, calcium, and other substances.

Primary treatments for coronary artery disease encompass various approaches such as medication, surgical interventions, additional therapies, and other related strategies. Medications include pharmaceutical substances such as clopidogrel, atorvastatin, metoprolol, lisinopril, losartan, amlodipine, nitroglycerin, among others. Diagnosis involves medical procedures such as electrocardiogram (ECG), echocardiogram, stress tests, cardiac catheterization, heart CT scans, and other diagnostic methods. These medications and diagnostic procedures are made available through diverse distribution channels such as hospital pharmacies, retail pharmacies, online pharmacy platforms, and others. The utilization of these treatments and diagnostic measures extends to hospitals, specialty clinics, and other healthcare facilities.

The coronary artery disease market research report is one of a series of new reports from The Business Research Company that provides coronary artery disease market statistics, including coronary artery disease industry global market size, regional shares, competitors with a coronary artery disease market share, detailed coronary artery disease market segments, market trends and opportunities, and any further data you may need to thrive in the coronary artery disease industry. This coronary artery disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The coronary artery disease market size has grown strongly in recent years. It will grow from $29.15 billion in 2024 to $31.97 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to prevalence of coronary artery disease, growth in minimally invasive surgeries, increase in sedentary lifestyles, aging population and cad prevalence, evolution of pharmacological treatments

The coronary artery disease market size is expected to see rapid growth in the next few years. It will grow to $48.48 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to growing lifestyle factors, focus on telemedicine and remote monitoring, expansion of interventional cardiology procedures, shift towards value-based healthcare models, and development of novel drug therapies. Major trends in the forecast period include the development of gene therapies, integration of artificial intelligence in diagnosis, focus on mental health in CAD care, rise in home-based healthcare services, and adoption of remote cardiac rehabilitation.

The increasing prevalence of coronary artery disease is anticipated to drive the growth of the coronary artery disease market in the coming years. Coronary artery disease (CAD) is a medical condition marked by the narrowing or blockage of the coronary arteries, which supply blood to the heart muscle. The rise in CAD cases can be attributed to dietary changes, stress, lack of exercise, obesity, aging, and other factors. Treatment options for coronary artery disease include medications such as clopidogrel, ticagrelor, warfarin, and heparin, as well as procedures like coronary artery bypass grafting, angioplasty, and stenting. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US-based federal agency under the Department of Health and Human Services, reported that coronary heart disease (CHD) was the leading type of heart disease, resulting in 371,506 deaths in 2022. Approximately 5% of adults aged 20 and older (1 in 20) were affected by coronary artery disease (CAD). In 2022, about 1 in 5 deaths from cardiovascular disease (CVD) occurred in adults under 65 years old. Therefore, the rise in the prevalence of coronary artery disease is expected to boost the coronary artery disease market during the forecast period.

The increasing aging population is expected to drive the growth of the coronary artery disease market in the future. An aging population refers to a demographic shift characterized by a growing proportion of elderly individuals within society over time. This aging demographic significantly contributes to the expansion of the coronary artery disease market, as older individuals are more vulnerable to this condition. For example, in October 2022, a report from the World Health Organization (WHO), a Switzerland-based agency focused on international public health, indicated that one in six people is projected to be 60 or older by 2030 worldwide. By 2050, the global population of individuals aged 60 and above is expected to reach 2.1 billion. Therefore, the rising aging population is driving the coronary artery disease market.

Prominent companies within the coronary artery disease market are directing their efforts toward developing cutting-edge technologies, including AI-based blood tests. These tests leverage artificial intelligence (AI) algorithms for the analysis and interpretation of blood-related data. For instance, in February 2023, Cardio Diagnostics Holdings, a US-based company specializing in AI-based integrated genetic-epigenetic engines, introduced PrecisionCHD. This innovative blood test combines genetic and epigenetic analyses to enable early identification of coronary heart disease. With a sensitivity of over 75% for both men and women, PrecisionCHD employs a machine-learning model derived from the analysis of billions of genomic and epigenomic data points, incorporating epigenetic (DNA methylation) and genetic (single nucleotide polymorphism) biomarkers.

Major companies in the coronary artery disease market are concentrating on developing innovative products, such as drug-coated balloon catheters, to drive revenue growth. Drug-coated balloon catheters are medical devices utilized in interventional cardiology to treat narrowed or blocked blood vessels, particularly in cases of coronary artery disease or peripheral artery disease. For example, in March 2024, Boston Scientific Corporation, a US-based medical device company, announced that the US Food and Drug Administration (FDA) had approved the AGENT Drug-Coated Balloon (DCB) for the treatment of coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR refers to the obstruction or narrowing of a stented vessel due to plaque or scar tissue. The AGENT DCB provides a specialized treatment option for the challenging issue of in-stent restenosis, addressing a significant unmet medical need. It is specifically designed for treating ISR as well as previously untreated small vessel coronary disease. Currently available in Europe, parts of Asia Pacific, and Latin America, the AGENT DCB offers a targeted solution for these complex cardiovascular conditions.

In April 2023, Abbott Laboratories, a prominent US-based medical devices and healthcare company, completed the acquisition of Cardiovascular Systems Inc. for a total consideration of $890 million. This strategic acquisition is designed to enhance Abbott's capabilities in addressing vascular disease by integrating the innovative solutions developed and commercialized by Cardiovascular Systems Inc. The latter, based in the United States, is a medical device company with a focus on creating and bringing to market advanced treatments for peripheral and coronary artery disease. This move is indicative of Abbott's commitment to expanding its portfolio and strengthening its position in the medical devices sector, particularly in the field of cardiovascular health.

Major companies operating in the coronary artery disease market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Gilead Sciences Inc., Amgen Inc. , Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Honya Medical Inc., Idorsia Pharmaceuticals Ltd., Cytokinetics Inc., Kowa Pharmaceuticals America Inc., Sinotau Pharmaceutical Group, HRV Global Life Sciences, Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum fur Herz- Kreislauf-Forschung (DZHK) e.V.

North America was the largest region in the coronary artery disease market in 2024. The regions covered in the coronary artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coronary artery disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The coronary artery disease market includes revenues earned by entities by providing coronary angioplasty, coronary artery bypass and heart transplant services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coronary Artery Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on coronary artery disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for coronary artery disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The coronary artery disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Medication; Surgery; Additional Therapy; Other Treatments
• 2) By Diagnosis: Electrocardiogram; Echocardiogram; Stress Test; Cardiac Catheterization; Heart CT Scan; Other Diagnosis
• 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Channels
• 4) By End-User: Hospitals; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Medication: Antiplatelet Agents; Beta-Blockers; Statins; ACE Inhibitors; Other Medications
• 2) By Surgery: Coronary Artery Bypass Grafting; Angioplasty And Stenting; Heart Valve Surgery; Other Surgical Interventions
• 3) By Additional Therapy: Cardiac Rehabilitation; Lifestyle Modification Programs; Alternative Therapies
• 4) By Other Treatments: Gene Therapy; Stem Cell Therapy; Innovative Devices
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Coronary Artery Disease Market Characteristics

3. Coronary Artery Disease Market Trends And Strategies

4. Coronary Artery Disease Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Coronary Artery Disease Growth Analysis And Strategic Analysis Framework

• 5.1. Global Coronary Artery Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Coronary Artery Disease Market Growth Rate Analysis
• 5.4. Global Coronary Artery Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Coronary Artery Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Coronary Artery Disease Total Addressable Market (TAM)

6. Coronary Artery Disease Market Segmentation

• 6.1. Global Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Surgery
• Additional Therapy
• Other Treatments
• 6.2. Global Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Electrocardiogram
• Echocardiogram
• Stress Test
• Cardiac Catheterization
• Heart CT Scan
• Other Diagnosis
• 6.3. Global Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Other Channels
• 6.4. Global Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Other End-Users
• 6.5. Global Coronary Artery Disease Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antiplatelet Agents
• Beta-Blockers
• Statins
• ACE Inhibitors
• Other Medications
• 6.6. Global Coronary Artery Disease Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coronary Artery Bypass Grafting
• Angioplasty And Stenting
• Heart Valve Surgery
• Other Surgical Interventions
• 6.7. Global Coronary Artery Disease Market, Sub-Segmentation Of Additional Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Rehabilitation
• Lifestyle Modification Programs
• Alternative Therapies
• 6.8. Global Coronary Artery Disease Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Therapy
• Stem Cell Therapy
• Innovative Devices

7. Coronary Artery Disease Market Regional And Country Analysis

• 7.1. Global Coronary Artery Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Coronary Artery Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Coronary Artery Disease Market

• 8.1. Asia-Pacific Coronary Artery Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Coronary Artery Disease Market

• 9.1. China Coronary Artery Disease Market Overview
• 9.2. China Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Coronary Artery Disease Market

• 10.1. India Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Coronary Artery Disease Market

• 11.1. Japan Coronary Artery Disease Market Overview
• 11.2. Japan Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Coronary Artery Disease Market

• 12.1. Australia Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Coronary Artery Disease Market

• 13.1. Indonesia Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Coronary Artery Disease Market

• 14.1. South Korea Coronary Artery Disease Market Overview
• 14.2. South Korea Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Coronary Artery Disease Market

• 15.1. Western Europe Coronary Artery Disease Market Overview
• 15.2. Western Europe Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Coronary Artery Disease Market

• 16.1. UK Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Coronary Artery Disease Market

• 17.1. Germany Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Coronary Artery Disease Market

• 18.1. France Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Coronary Artery Disease Market

• 19.1. Italy Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Coronary Artery Disease Market

• 20.1. Spain Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Coronary Artery Disease Market

• 21.1. Eastern Europe Coronary Artery Disease Market Overview
• 21.2. Eastern Europe Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Coronary Artery Disease Market

• 22.1. Russia Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Coronary Artery Disease Market

• 23.1. North America Coronary Artery Disease Market Overview
• 23.2. North America Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Coronary Artery Disease Market

• 24.1. USA Coronary Artery Disease Market Overview
• 24.2. USA Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Coronary Artery Disease Market

• 25.1. Canada Coronary Artery Disease Market Overview
• 25.2. Canada Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Coronary Artery Disease Market

• 26.1. South America Coronary Artery Disease Market Overview
• 26.2. South America Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Coronary Artery Disease Market

• 27.1. Brazil Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Coronary Artery Disease Market

• 28.1. Middle East Coronary Artery Disease Market Overview
• 28.2. Middle East Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Coronary Artery Disease Market

• 29.1. Africa Coronary Artery Disease Market Overview
• 29.2. Africa Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Coronary Artery Disease Market Competitive Landscape And Company Profiles

• 30.1. Coronary Artery Disease Market Competitive Landscape
• 30.2. Coronary Artery Disease Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Coronary Artery Disease Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Bristol-Myers Squibb Company
• 31.3. AstraZeneca plc
• 31.4. Abbott Laboratories
• 31.5. GlaxoSmithKline plc
• 31.6. Gilead Sciences Inc.
• 31.7. Amgen Inc.
• 31.8. Viatris Inc.
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Aurobindo Pharma Ltd.
• 31.11. Hikma Pharmaceuticals plc
• 31.12. Amneal Pharmaceuticals Inc.
• 31.13. Chiesi Farmaceutici S.p.A.
• 31.14. Lupin Pharmaceuticals Inc.
• 31.15. Wockhardt Ltd.

32. Global Coronary Artery Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Coronary Artery Disease Market

34. Recent Developments In The Coronary Artery Disease Market

35. Coronary Artery Disease Market High Potential Countries, Segments and Strategies

• 35.1 Coronary Artery Disease Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Coronary Artery Disease Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Coronary Artery Disease Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer